| | DRUG: Labetuzumab | |
Entry |
|
Name |
Labetuzumab (INN/USAN) |
Efficacy |
Antineoplastic, Anti-CEA antibody |
Type |
Monoclonal antibody |
Comment |
Treatment of colorectal cancer
|
Target |
|
Brite |
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Cell adhesion molecules: Ig superfamiy
CAMs
CEACAM
D08936 Labetuzumab (INN/USAN)
|
Other DBs |
|
|
» Japanese version » Back
|
|